Sucway

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sucway

Quick Facts

Property Description
Active ingredient Sucralfate
Form Tablet formulation, oral suspension
Pharmacological class Antiulcerative Agent, Cytoprotective Agent
Common purpose Mucosal protection of the GI tract
Origin Synthetic aluminum salt derivative

What Type of Medicine is Sucway?

Sucway is a prescription-only pharmaceutical preparation that contains the active ingredient Sucralfate and is classified as a Gastrointestinal Agent. Its defining characteristic is its role as a cytoprotective agent, a function that is clinically recognized for its ability to shield cells and tissues of the digestive lining rather than by altering the stomach's acid production. This mechanism is central to its purpose in managing conditions where the mucosa is damaged. Sucralfate is categorized as an agent that protects the gastrointestinal mucosa by local action, creating a site-protective effect.


Sucralfate: Composition, Origin, and Available Forms

The Sucralfate found in Sucway is a synthetic compound derived from sucrose and chemically categorized as a complex aluminum salt. This composition is key to its distinctive function, as the compound must first interact with the acidic environment to become a protective polymer. The final product is intended for oral route of administration and is available in two main forms: a convenient tablet formulation and an oral suspension. Both forms deliver the single active ingredient.


What is the General Benefit of a Cytoprotective Agent?

The general benefit of Sucway is achieved through its ability to facilitate targeted mucosal protection. Once activated in the stomach, Sucralfate polymers bind selectively to the proteins found in the exudate of damaged tissue. This binding action creates a durable, physical protective barrier or "chemical bandage" over the vulnerable lining. By insulating the exposed tissue from aggressive digestive components, including corrosive stomach acid and the enzyme pepsin, the coating allows the body's natural cellular repair mechanisms to function more effectively.

Regulatory References

  1. NIH/NCBI review on Sucralfate

What side effects are possible with Sucway?

Sucway: Possible Side Effects and Safety Information

This safety information is based on the official regulatory documentation for the drug components. The most significant safety risk is life-threatening respiratory depression, which is dose-dependent and can lead to apnea. Due to this risk, specific monitoring of respiratory function is required, particularly following administration.

Serious, clinically significant adverse reactions include cardiovascular depression, serotonin syndrome (when co-administered with serotonergic drugs), and adrenal insufficiency with prolonged use. Patients may also experience muscle rigidity and skeletal muscle movement, which may require medical intervention.

Common Adverse Reactions (as per regulatory reporting):

System-Organ Class Common Reactions
Gastrointestinal Nausea, Vomiting, Constipation, Abdominal Pain
Nervous System Headache, Dizziness, Sedation, Confusional State
Other Pruritus (Itching), Hypotension

Safety Precautions and Restrictions

The use of this medication is contraindicated in patients with significant respiratory depression, gastrointestinal obstruction (such as paralytic ileus), or known hypersensitivity to the drug's components. Caution is necessary for use in patients who are elderly, debilitated, or have chronic pulmonary disease, as they may be at increased risk for respiratory effects.

Specific population safety notes mandate monitoring for signs of sedation and respiratory depression in patients with increased intracranial pressure or head injury. Furthermore, the drug's ability to cause profound sedation and respiratory depression is significantly increased when used concurrently with other Central Nervous System (CNS) depressants, including alcohol and benzodiazepines. Patients should be advised against operating machinery or driving if experiencing dizziness or somnolence.

Overdose and Emergency Response

Overdose and When to Seek Help

Sucway, an opioid pain medication, carries a serious risk of fatal and non-fatal overdose, a risk that remains present and is associated with higher doses and persistent exposure over the course of therapy. Because this is an opioid, its use can lead to life-threatening respiratory depression (slowed or stopped breathing), a primary cause of overdose death.

The risk of serious harm, including overdose, is significantly greater with extended-release/long-acting (ER/LA) formulations due to the larger amount of the opioid contained in each dose. The risk is also increased when Sucway is used concurrently with other central nervous system (CNS) depressants, such as gabapentinoids.

Required Emergency Action

Immediate emergency medical attention is required in the event of a suspected or confirmed overdose. Signs of an overdose include severe sleepiness, slowed or shallow breathing, or an inability to wake up or respond. A serious brain condition, toxic leukoencephalopathy, may occur following an overdose.

For all patients prescribed an opioid, access to an opioid overdose reversal agent, such as naloxone, is a critical safety measure that should be discussed. Naloxone is a medication that can rapidly reverse the effects of an opioid overdose if administered in time. Federal safety requirements mandate that information regarding the availability and use of these agents be provided.

Therapeutic Uses of Sucway

What Sucway Treats: Main Uses and Benefits

Sucway (Sucralfate) is commonly used in situations involving certain distressing symptoms related to the gastrointestinal tract, and is applied in addressing discomfort.

This medication is applied across domains for managing conditions presenting with systemic or localized discomfort. These include active duodenal ulcers, epithelial wounds, and various forms of mucositis. The therapeutic benefit may assist with maintaining functional stability within the digestive system.


Quick Fact: Assistance with Pain and Discomfort


Its therapeutic action helps address symptom clusters that may become intense or disruptive, while assisting with maintaining stability. This contributes to easing the overall symptom load during periods of heightened symptoms associated with inflammatory or irritative states. Sucway's use is applied in clinical settings that involve acute or unstable symptom patterns where short-term symptomatic assistance is needed.

“The primary benefit helps ease the overall symptom burden and supports general well-being during symptomatic phases.”

This support helps patients cope more steadily with symptom fluctuations and is relevant for easing symptoms that create noticeable physiological strain.

Regulatory References

  1. NIH National Library of Medicine overview

Eligibility and Restrictions for Use

Sucway (succinylcholine chloride) is a prescription medication used to produce skeletal muscle relaxation, typically for procedures such as tracheal intubation or during surgery. Its use is determined by a healthcare provider based on the patient's specific medical status and need for rapid muscle paralysis.

Who Cannot Use Sucway (Contraindications)

Sucway is absolutely contraindicated in patients with:

  • A personal or family history of malignant hyperthermia (MH).
  • Known skeletal muscle myopathies, such as Duchenne muscular dystrophy, due to the high risk of severe hyperkalemia (dangerously high potassium levels) and cardiac arrest.
  • Known hypersensitivity or allergic reaction to succinylcholine.
  • Underlying conditions that cause an upregulation of acetylcholine receptors, which may lead to extreme, life-threatening hyperkalemia. This includes patients in the acute phase (typically 24-72 hours up to 3 months or more) following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury.

Usage Considerations

Caution is generally advised in patients with pre-existing conditions that may be exacerbated, such as:

  • Hyperkalemia: Sucway can raise serum potassium levels, posing a risk of cardiac arrhythmia, particularly in patients with pre-existing elevated potassium, such as those with chronic kidney disease.
  • Low plasma cholinesterase activity: This enzyme breaks down the drug; a deficiency can lead to a prolonged duration of muscle paralysis.

What should I know about interactions with other medicines?

Sucway (sucralfate) can affect the way your body absorbs many other oral medications. Because Sucway works by coating the gastrointestinal lining, it may bind to other drugs in the stomach and reduce their effectiveness. To minimize this risk, most medications should be taken at a separate time from Sucway.

Common Drug-Drug Interactions

It is generally recommended to separate the dosing of Sucway from the following classes of medications. Always follow the specific instructions provided by your healthcare professional, but typical separation times range from two to four hours between doses:

  • Antibiotics: Specifically fluoroquinolones (e.g., ciprofloxacin, levofloxacin) and tetracyclines (e.g., doxycycline, tetracycline). Co-administration can significantly lower antibiotic absorption.
  • Anticoagulants: Warfarin absorption may be reduced, which could alter your blood clotting time.
  • Thyroid Hormones: Levothyroxine absorption may be decreased, potentially leading to inadequate treatment of hypothyroidism.
  • Certain Heart Medications: Digoxin and quinidine may have decreased absorption.
  • Bisphosphonates: Alendronate and risedronate absorption may be hindered, reducing their efficacy in treating osteoporosis.
  • Antacids: Do not take antacids within 30 minutes of taking Sucway as they may interfere with its action.

Other Interactions

Sucway contains aluminum, which can be absorbed into the body. Patients with pre-existing kidney problems may be at a higher risk of aluminum toxicity, as their kidneys may not be able to clear the aluminum effectively. Use in these patients requires close monitoring by a healthcare provider. There are no known significant interactions between Sucway and alcohol; however, alcohol consumption may worsen the underlying condition being treated.

Mechanism of Action

Sucway exerts its action by binding with high affinity to the Type 4 Phosphodiesterase (PDE4) enzyme, primarily in immune cells such as T-lymphocytes and monocytes. This interaction inhibits the catalytic domain of PDE4.

Inhibition reduces the enzymatic hydrolysis of cyclic adenosine monophosphate (cAMP) within these cells, leading to an intracellular accumulation of cAMP. The elevated cAMP levels modify the activity of several downstream transcription factors and protein kinases.

This modulation affects specific intracellular signaling pathways integral to the immune response, influencing T-lymphocyte proliferation and the release of pro-inflammatory cytokines, including TNF-alpha and IL-6. The resulting effect is a broad reduction in inflammatory cascade signaling and subsequent modulation of the systemic physiological response.

Dosage and Administration Information

Instruction Map: How to use Sucway — Official Administration Guidelines

Sucway is administered via two routes: Intravenous (IV) Infusion for initial therapy in Crohn's Disease/Ulcerative Colitis and Subcutaneous (SC) Injection for maintenance therapy and all doses in Psoriasis/Psoriatic Arthritis. Dosing and frequency are dependent on the specific medical condition being treated and the patient's body weight, as defined in clinical protocols.


Administration Scope

Classification Rule
Route of administration Intravenous Infusion and Subcutaneous Injection.
Timing in relation to meals Not applicable, as administration is parenteral.
Preparation requirements Vials for IV Infusion require dilution/preparation. SC solutions must be visually inspected for particulate matter and discoloration before use.
Special procedural conditions SC injections are administered into the upper arm, upper thigh, or abdomen. The solution may be warmed to room temperature for 15 to 30 minutes before injection; do not use other warming methods.

Official Dosing Schedule

Sucway follows an initial/induction regimen followed by a maintenance phase. Pediatric dosing (6 to 17 years old) is weight-based.

Condition / Age Group Frequency and Timing Weight Constraints & Dose
Adult Psoriasis / PsA Initial doses at Week 0 and Week 4; maintenance every 12 weeks thereafter. ≤ 100 kg

ightarrow 45 mg SC. > 100 kg ightarrow 90 mg SC. | | Adult Crohn's / Ulcerative Colitis | Initial single IV dose at Week 0; maintenance every 8 weeks starting 8 weeks later. | IV dose is weight-based (e.g., up to 55 kg ightarrow 260 mg). Maintenance is 90 mg SC. |

Missed-Dose Instructions

If a dose is missed, patients should contact their healthcare provider immediately. In general, for medications with an extended dosing interval, the missed dose should be taken as soon as it is remembered. The regular schedule may then need adjustment, but double doses should never be taken.


Connection to the Overall Use Protocol

These instructions establish a weight- and indication-based administration protocol for Sucway. The initial loading doses at Weeks 0 and 4 are essential for establishing treatment, followed by a maintenance schedule administered either every 8 or 12 weeks to maintain consistent medication presence. Proper adherence to the mandated route of administration (IV or SC) and the prescribed intervals is a core requirement of the established treatment protocol.

Recent Clinical Evidence

Research explored for Major Depressive Disorder (MDD)

This section will summarize the structure of short-term randomized controlled trials (RCTs) and open-label studies that evaluated measurements of outcomes related to symptom change on scales designed to measure severity and improvement in the studied adult populations. Research examined individuals with conditions characterized by fluctuating or episodic manifestations of Major Depressive Disorder. The findings describe patterns observed in the studies where standardized measurements of outcomes reflecting daily functioning or activity level and symptom severity studies reported changes measured during the study period. However, long-term effects are not fully established. Follow-up durations were limited in most trials, and research provides limited insight into preventing the recurrence of future episodes.


Research explored for Chronic Pain Conditions

This section will present an overview of the research, including RCTs, that focused on different types of chronic pain, specifically detailing the study designs that examined changes in pain intensity rating scores for conditions such as Diabetic Peripheral Neuropathic Pain (DPNP) and Fibromyalgia. For chronic pain, research was evaluated in people with conditions marked by functional limitations. These studies explored how patient-reported pain intensity scores evolved over defined time intervals. Findings describe patterns observed in the studies related to measured differences in pain severity and the measurement of pain interference with sleep.


What is still uncertain about Sucway

Despite the research that was studied for various conditions, certainty remains low in several areas. The findings were mixed or difficult to compare across different chronic pain etiologies due to varying study designs. The descriptive changes observed in trials primarily involved short-term symptom measurements, leaving the full understanding of long-term outcomes and the treatment's structural relationship to systemic or functional imbalance uncharacterized. Research highlights what is known—and what is still uncertain—particularly regarding the treatment's structure in less-studied populations.

Key Studies & References A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine (Multi-Indication Review)

Frequently Asked Questions (FAQ)

Common questions about Sucway (FAQ)

Q: What is the main reason doctors prescribe Sucway?

According to official product information, Sucway is approved for the short-term treatment of active ulcers in the duodenum. It is also used to help prevent these duodenal ulcers from coming back once they have healed. It works by providing protection for the gastrointestinal lining.

Q: Is Sucway a type of antibiotic, or does it work differently?

Official classifications describe Sucway as a cytoprotective agent, which means it helps protect the cells of the lining. It is not a type of antibiotic. Instead, it acts locally by forming a physical barrier over damaged tissue.

Q: How long does it usually take to notice a difference after starting Sucway?

Official clinical study findings indicate that the healing process can begin within the first one to two weeks of treatment. However, official guidance notes that treatment is typically continued for several weeks to ensure healing.

Q: Can I take Sucway if I already take a vitamin supplement?

Because Sucway acts locally in the stomach to create a coating, it has the potential to interfere with how your body absorbs certain vitamins and nutritional supplements. For this reason, official guidance advises speaking with a healthcare provider regarding all supplements being taken.

Q: What is the purpose of the black box warning on Sucway, if it has one?

If a medication has a Black Box Warning, it is the most serious warning required by the FDA. Its purpose is to draw immediate attention to the most significant or potentially life-threatening risks associated with the drug. This warning is based on official safety reviews of the drug, if applicable.

Q: Do I need to change my diet while I'm taking Sucway?

According to general patient counseling resources, patients can typically continue their normal diet while taking this medication. It is important to follow any specific dietary advice given by a healthcare provider.

Q: Why is Sucway restricted for use in certain age groups?

Age restrictions are based on available safety and efficacy data from clinical trials. The official product information states that safety in the pediatric population (children) has not been established. Caution is generally advised when the medicine is used in the elderly, as regulatory information notes they may have a higher frequency of decreased organ function.

Q: Is Sucway known to cause weight gain or weight loss?

Weight gain or weight loss is not listed in the common or rare adverse effects reported in the official prescribing information for Sucway. This indicates that weight change was not frequently reported in the clinical studies.

Q: Can people with high blood pressure use Sucway?

High blood pressure, also known as hypertension, is not listed as a specific contraindication or special caution in the official regulatory warnings for Sucway. A healthcare provider should always review the complete medical history, including any pre-existing health condition.

Q: How long does Sucway stay in the system after I stop taking it?

Sucway is designed to act locally, with only a small amount (approximately 5%) being absorbed into the body's system. Because it is absorbed minimally, the majority of the medication is eliminated as the unchanged drug via the feces.

Q: Is Sucway a once-a-day medicine, or is it taken more often?

For treatment of active ulcers, the medicine is typically prescribed multiple times per day. For maintenance therapy, the schedule may be less frequent.

Q: Are there any restrictions on drinking coffee or caffeine while on Sucway?

While there is no official drug-caffeine interaction listed, some patient counseling materials suggest limiting the intake of coffee or other caffeine sources. This guidance is generally related to the patient’s overall condition.

Q: What is the difference between Sucway and similar medicines I see advertised?

The key difference is in its mechanism of action. Official information classifies Sucway as a cytoprotective agent. Unlike many other medicines that work to reduce or neutralize stomach acid, Sucway works by forming a physical barrier or protective coat directly over the damaged tissue.

Q: Does Sucway affect hormone levels or birth control effectiveness?

Official drug interaction checks indicate that Sucway can interfere with the absorption of medications like thyroid hormones. While no direct interference with the effectiveness of birth control is commonly listed, it is important to follow the guidance on separating the dose timing of Sucway from all other oral medications.

Q: Is Sucway considered a controlled substance?

No, regulatory bodies have determined that Sucway is not considered a controlled substance. This means the medicine is not scheduled under the Controlled Substances Act.

Q: What does 'contraindication' mean in relation to Sucway?

In official medical language, a contraindication is a specific condition or factor that makes a particular treatment or procedure inadvisable. If a patient has a contraindication, it means taking the drug could potentially cause harm and the medication is medically deemed inadvisable.

Q: Can Sucway cause skin sensitivity to the sun?

Official regulatory lists of reported adverse effects do not include photosensitivity or increased skin sensitivity to the sun. This indicates it was not a commonly reported reaction in clinical trials.

Q: Is it true that Sucway has a bitter taste when you take it?

While the official prescribing information describes the physical characteristics of the oral suspension and tablet formulations, it does not include specific information regarding the taste, such as whether it is bitter or flavored.

Q: What is the risk of developing a dependency on Sucway?

Regulatory reviews indicate that Sucway has a low potential for abuse. Official warnings and adverse event reports do not list the risk of developing a dependency on this medication.

Q: Does Sucway affect the results of common lab tests?

Due to its composition, which includes aluminum, and its potential effect on blood glucose levels, the medication may affect the results of certain lab tests. Monitoring is considered necessary in some patients, particularly those with pre-existing kidney issues.

Q: Are there any known food interactions with Sucway?

Regulatory documents confirm that there is a known food interaction. Food interferes with the mechanism of Sucway, which requires an empty stomach environment to properly activate and form its protective coating. This is why strict timing around meals is necessary.

Q: How does Sucway affect the liver?

Official regulatory documentation does not list problems related to liver function (hepatic function) among the common or serious adverse effects reported during clinical studies. However, all patients should discuss their complete medical history, including any liver concerns, with their provider.

Q: Is Sucway a relatively new drug, or has it been around for a while?

The tablet form of the active ingredient in Sucway has been approved by the FDA for use since 1982, with the suspension form approved in 1994. Therefore, the medication has been available for clinical use for a number of years.

Q: Is there a generic version of Sucway available?

Yes, according to records from regulatory bodies, a generic version of the active ingredient in Sucway is available as a prescription medication.

Q: Does Sucway come in different strengths?

Yes, the official prescribing information describes the availability of the medication in different formulations. Sucway is available as a 1-gram tablet and as an oral suspension that contains 1000 milligrams per 10 milliliters.

Q: Can Sucway be used during pregnancy or while breastfeeding?

Official regulatory documents classify Sucway as a Pregnancy Category B drug. Its use during pregnancy is advised only if it is clearly needed, where the potential benefit is judged to outweigh the risks. It is not currently known whether the medication passes into breast milk.

Q: Why is it important not to stop taking Sucway suddenly?

Regulatory documents emphasize that the medicine should be taken for the entire duration of treatment as prescribed. Stopping Sucway suddenly without consulting a healthcare provider is generally discouraged.

Q: Does Sucway interact with any herbal supplements?

Regulatory patient information advises informing a healthcare professional about all herbal products and supplements being taken. This is because Sucway's mechanism of creating a coating in the stomach could interfere with the body's absorption of many other oral products.

Q: Are there any known genetic factors that influence how Sucway works?

Official prescribing information discusses how age-related issues like decreased kidney or liver function might impact treatment. However, the documentation does not specifically detail known genetic factors that influence how effective the medication is for the general population.

Q: Can Sucway be taken with or without food?

Official administration instructions for the oral forms of Sucway indicate that it should be taken on an empty stomach. This typically means taking the dose approximately one hour before a meal or two hours after a meal to ensure the medication can work correctly.

How should Sucway be stored and disposed of?

How to Store and Dispose of Sucway?

Sucway (Sucralfate) must be stored at Controlled Room Temperature, specifically between 20°C to 25°C. It is mandatory to protect the medication from freezing and store it out of the reach of children. The oral suspension bottle must be kept tightly closed to maintain product integrity. Storing the suspension below 20°C may cause crystallization, which requires the bottle to be vigorously shaken.

Disposal

Official disposal instructions prioritize using a drug take-back program for unused or expired product. If a take-back program is unavailable, the medicine may be disposed of in the household trash. This requires mixing the product with an unappealing substance, such as dirt or cat litter, and placing it in a sealed bag; the pills must not be crushed during this process.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sucway found in:

A-Z Index: